118 related articles for article (PubMed ID: 1909017)
1. [In vitro antibacterial activity of a new oral cephalosporin, ceftibuten. Results of a multicenter study].
Soussy CJ; Meyran M; Chanal M; Reverdy ME; Kitzis MD; Derlot E
Pathol Biol (Paris); 1991 May; 39(5):396-402. PubMed ID: 1909017
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibacterial activity of RU 51746 (sodium salt of cefpodoxime). Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Kitzis MD; Chanal C; Mounier M; Derlot E; Vergnaud M
Pathol Biol (Paris); 1990 May; 38(5):336-42. PubMed ID: 2195445
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study].
Soussy CJ; Kitzis MD; Thabaut A; Chanal M; Bure A; Vergnaud M; Reynaud AE; Coulet M; Dabernat H; Muller-Serieys C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):528-33. PubMed ID: 2508039
[TBL] [Abstract][Full Text] [Related]
4. [Antibacterial effect of cefixime].
Soussy CJ; Meyran M; Duval J
Presse Med; 1989 Oct; 18(32):1546-50. PubMed ID: 2530528
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study].
Soussy CJ; Morel C; Kitzis MD; Meyran M; Brun Y; Joly-Guillou ML; Dabernat H; Chanal M; Courtieu AL; Derlot E
Pathol Biol (Paris); 1991 May; 39(5):403-9. PubMed ID: 1881670
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antibacterial activity of cefpirome: a new cephalosporin; results of a multicenter study].
Soussy CJ; Chanal M; Derlot E; Goldstein F; Duval J
Pathol Biol (Paris); 1994 Oct; 42(8):754-60. PubMed ID: 7724247
[TBL] [Abstract][Full Text] [Related]
7. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
[TBL] [Abstract][Full Text] [Related]
8. [In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve].
Soussy CJ; Kitzis MD; Chanal C; Carret G; Derlot E
Pathol Biol (Paris); 1991 May; 39(5):367-73. PubMed ID: 1652727
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve].
Soussy CJ; Duval J; Chanal M; Sirot D; Bergogne-Bérézin E; Joly-Guillou ML; Malbruny B; Morel C
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):660-4. PubMed ID: 3054743
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Jones RN; Barry AL
Chemioterapia; 1988 Oct; 7(5):283-6. PubMed ID: 3147148
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of imipenem against hospital bacteria].
Soussy CJ; Duval J
Presse Med; 1990 Apr; 19(13):583-7. PubMed ID: 2139936
[TBL] [Abstract][Full Text] [Related]
12. Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features.
Jones RN
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S77-83. PubMed ID: 7567314
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
[TBL] [Abstract][Full Text] [Related]
14. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
[TBL] [Abstract][Full Text] [Related]
15. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
Neu HC; Chin NX; Labthavikul P
Infection; 1985; 13(3):146-55. PubMed ID: 3928497
[TBL] [Abstract][Full Text] [Related]
16. [Multicenter study of the antibacterial activity of a new cephalosporin: CM 40874].
Duval J; Soussy CJ; Deforges L; Brun Y; Coulet M; Forey F; Thabaut A; Meyran M; Acar JF; Kitzis MD
Pathol Biol (Paris); 1984 May; 32(5):331-4. PubMed ID: 6547524
[TBL] [Abstract][Full Text] [Related]
17. [A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].
Ergova R; K'oleian E; Kharalambieva Ia; Mitov I; Docheva Iu
Vutr Boles; 2000; 32(1):13-7. PubMed ID: 11195191
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
Chin NX; Gu JW; Neu HC
Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):685-91. PubMed ID: 2226499
[TBL] [Abstract][Full Text] [Related]
19. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of LY164846, a new oral cephalosporin, and recommendations for disk diffusion tests.
Sassine-Nawas G; Baker CN; Thornsberry C
Diagn Microbiol Infect Dis; 1987 Jan; 6(1):41-8. PubMed ID: 3100126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
